查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1632986

免疫療法藥物市場：2033 年市場分析與預測 - 按類型、產品、應用、技術、最終用戶、流程、模式和階段

Immunotherapy Drugs Market Analysis and Forecast to 2033: Type, Product, Application, Technology, End User, Process, Mode, Stage
出版日期: | 出版商: Global Insight Services | 英文 361 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

免疫療法市場規模預計將從 2023 年的 1,630 億美元成長到 2033 年的 3,750 億美元，複合年增長率為 8.5%。

免疫療法市場涵蓋致力於開發和商業化治療劑的行業，這些治療劑利用和增強人體免疫系統來對抗疾病，包括癌症和自體免疫疾病。該市場包括單株抗體、檢查點抑制劑、疫苗和細胞療法，代表著向個人化醫療的範式轉變，並為改善患者預後和創新治療提供了有希望的途徑。

市場成長主要得益於癌症治療和自體免疫疾病管理的進步。單株抗體因其在治療各種癌症方面的針對性作用和功效而引領市場。檢查點抑制劑因其能夠激發人體對腫瘤的免疫反應而受到廣泛關注，是表現第二好的細分領域。北美地區佔據市場主導地位，得益於強大的醫療保健基礎設施和大量的研發投資。受政府優惠政策和新療法日益普及的推動，歐洲緊隨其後。在這些地區中，美國和德國表現最佳，反映了他們對創新和獲得先進醫療保健解決方案的承諾。亞太地區正在成為一個充滿希望的市場，這得益於醫療支出的增加和患者人數的增加，尤其是在中國和印度。這些見解強調了免疫治療藥物市場的動態性質和良好機會。

2023年免疫療法藥物市場呈現強勁成長，市場規模達3.2億單位。單株抗體領域佔最大的市場佔有率，為 45%，其次是免疫檢查點抑制劑，為 30%，癌症疫苗為 25%。這種分佈反映了全球範圍內標靶療法的採用日益增多以及癌症發病率的上升。單株抗體領域尤其受到生物技術和個人化醫療進步的推動。

競爭格局由羅氏、默克和百時美施貴寶等大公司主導，它們各自利用策略夥伴關係和創新研發來提升其市場地位。 FDA 核准和專利法等法規的影響對市場動態有重大影響。未來預測表明，在技術進步和醫療保健支出增加的推動下，到 2033 年其複合年增長率將達到 10%。由於新興市場的商機及新型免疫療法藥物的開發，市場呈現擴大趨勢。然而，課題依然存在，包括治療成本上升和監管要求更加嚴格。人工智慧在藥物開發中的整合預計將進一步推動成長。

北美主導免疫療法市場，主要由美國主導。該地區受益於強大的醫療保健基礎設施和大量的研發投資。大型製藥公司的存在及其對創新的重視進一步增強了市場。該地區慢性病的高發性也推動了對先進治療方案的需求。

歐洲佔免疫療法藥物市場的大部分佔有率，其中德國、法國和英國是主要貢獻者。該地區完善的醫療保健體系和強大的監管框架支持市場成長。歐洲國家也正在投資個人化醫療，推動免疫療法藥物的採用。該地區也高度重視癌症研究和治療創新。

亞太地區是一個快速成長的免疫療法市場。醫療費用的上漲和人們對先進治療的認識的不斷提高促進了這個市場的擴張。中國和印度等國家正在投資醫療保健基礎設施和研究項目。這些國家的癌症和其他慢性病發生率不斷上升，對有效的免疫療法治療的需求日益增長。

拉丁美洲和中東及非洲正逐漸成為免疫治療藥物市場的關鍵地區。儘管這些地區目前的市場佔有率較小，但醫療保健投資的增加和先進醫療治療機會的改善預計將推動成長。這些地區的政府正致力於改善醫療設施和研發，以支持市場發展。

目錄

第 1 章 免疫療法市場概論

  • 研究目標
  • 免疫療法市場定義與範圍
  • 報告限制
  • 調查年份與貨幣
  • 研究方法

第 2 章執行摘要

第 3 章 關鍵市場考量

第 4 章 免疫治療藥物市場展望

  • 免疫療法市場區隔
  • 市場動態
  • 波特五力分析
  • PESTLE 分析
  • 價值鏈分析
  • 4P模型
  • 安索夫矩陣

第5章 免疫治療藥物的市場策略

  • 母公司市場分析
  • 供需分析
  • 消費者購買意向
  • 個案研究分析
  • 價格分析
  • 監理狀態
  • 供應鏈分析
  • 競爭產品分析
  • 近期發展

第6章 免疫治療藥物市場規模

  • 免疫治療藥物市場規模（以價值計算）
  • 免疫治療藥物市場規模（以數量計算）

第7章 免疫治療藥物市場按類型劃分

    市場概況
  • 單株抗體
  • 檢查點抑制劑
  • 細胞因子
  • 癌症疫苗
  • 過繼性細胞療法
  • 溶瘤病毒療法
  • 其他

第 8 章 免疫療法市場（依產品）

    市場概況
  • 治療性疫苗
  • 免疫檢查點抑制劑
  • 非特異性免疫治療藥物
  • 癌細胞病毒免疫治療
  • CAR-T細胞療法
  • 其他

第 9 章 免疫療法市場（依應用）

    市場概況
  • 癌症
  • 自體免疫疾病
  • 傳染病
  • 發炎性疾病
  • 其他

第 10 章 免疫療法市場（依技術劃分）

    市場概況
  • 基因編輯
  • CRISPR
  • RNA幹擾 奈米科技
  • 重組DNA技術
  • 其他
第 11 章 免疫治療藥物市場（依最終使用者）
    市場概況
  • 醫院
  • 診所
  • 研究機構
  • 生物製藥公司
  • 其他

第 12 章 免疫治療藥物市場（依流程劃分）

    市場概況
  • 製造
  • 研究與開發
  • 臨床試驗
  • 監理機關核准
  • 啟動
  • 其他

第 13 章 免疫治療藥物市場（按模式）

    市場概況
  • 靜脈注射
  • 口服
  • 本地
  • 吸入
  • 其他
第 14 章：免疫療法市場（依階段）
    市場概況
  • 藥物研發
  • 臨床前
  • 臨床試驗
  • 授權
  • 啟動
  • 上市後監測
  • 其他

第 15 章 免疫治療藥物市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 瑞典
    • 瑞士
    • 丹麥
    • 芬蘭
    • 俄羅斯
    • 其他歐洲國家
    亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞
    • 新加坡
    • 印尼
    • 台灣
    • 馬來西亞
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區

第 16 章 競爭格局

  • 概述
  • 市佔率分析
  • 主要公司的定位
  • 衝突領導地圖
  • 供應商基準測試
  • 對標發展策略

第 17 章 公司簡介

  • Incyte
  • BeiGene
  • MacroGenics
  • Adaptimmune Therapeutics
  • Immunomedics
  • Kite Pharma
  • Juno Therapeutics
  • Immunocore
  • Bluebird Bio
  • Celldex Therapeutics
  • OncoMed Pharmaceuticals
  • Argenx
  • Cellectis
  • Fate Therapeutics
  • Gritstone Oncology
  • Adaptimmune
  • Allogene Therapeutics
  • Iovance Biotherapeutics
  • Zymeworks
  • Compugen
簡介目錄
Product Code: GIS24892

The immunotherapy drugs market is estimated to expand from $163 billion in 2023 to $375 billion by 2033, with a compound annual growth rate (CAGR) of 8.5%.

The Immunotherapy Drugs Market encompasses the industry dedicated to developing and commercializing therapeutic agents that harness and enhance the body's immune system to combat diseases, notably cancer and autoimmune disorders. This market includes monoclonal antibodies, checkpoint inhibitors, vaccines, and cell therapies, representing a paradigm shift towards personalized medicine and offering promising avenues for improved patient outcomes and innovative treatment modalities.

The market is witnessing growth, primarily driven by advancements in cancer treatment and autoimmune disease management. Monoclonal antibodies lead the market, owing to their targeted action and efficacy in treating various cancers. Checkpoint inhibitors are the second highest performing sub-segment, gaining traction due to their ability to unleash the body's immune response against tumors. The North American region dominates the market, supported by strong healthcare infrastructure and significant R&D investments. Europe follows closely, bolstered by favorable government policies and increased adoption of novel therapies. Within these regions, the United States and Germany are the top-performing countries, reflecting their commitment to innovation and access to advanced healthcare solutions. The Asia-Pacific region is emerging as a lucrative market, driven by increasing healthcare expenditure and a growing patient population, particularly in China and India. These insights underscore the dynamic nature of the immunotherapy drugs market and the promising opportunities it presents.

In 2023, the Immunotherapy Drugs Market demonstrated robust growth, with the market volume reaching 320 million units. The monoclonal antibodies segment holds the largest market share at 45%, followed by immune checkpoint inhibitors at 30%, and cancer vaccines at 25%. This distribution reflects the increasing adoption of targeted therapies and the rising incidence of cancer worldwide. The monoclonal antibodies segment is particularly driven by advancements in biotechnology and personalized medicine.

The competitive landscape is dominated by key players such as Roche, Merck & Co., and Bristol-Myers Squibb, each leveraging strategic partnerships and innovative R&D to enhance their market positions. Regulatory influences, including FDA approvals and patent laws, significantly impact market dynamics. The market is poised for expansion, with opportunities in emerging markets and the development of novel immunotherapeutic agents. However, challenges such as high treatment costs and stringent regulatory requirements persist. The integration of artificial intelligence in drug development is expected to further propel growth.

North America dominates the immunotherapy drugs market, primarily driven by the United States. The region benefits from a robust healthcare infrastructure and significant investment in research and development. The presence of leading pharmaceutical companies and a strong focus on innovation further bolster this market. The high prevalence of chronic diseases in the region also fuels demand for advanced treatment options.

Europe holds a substantial share in the immunotherapy drugs market, with Germany, France, and the United Kingdom being key contributors. The region's well-established healthcare system and strong regulatory framework support market growth. European countries are also investing in personalized medicine, which enhances the adoption of immunotherapy drugs. The emphasis on cancer research and treatment innovation is a driving force in this region.

Asia Pacific is experiencing rapid growth in the immunotherapy drugs market. Rising healthcare expenditures and increasing awareness about advanced treatments contribute to this expansion. Countries like China and India are investing in healthcare infrastructure and research initiatives. The growing prevalence of cancer and other chronic diseases in these countries increases the demand for effective immunotherapy treatments.

Latin America and the Middle East & Africa regions are gradually emerging in the immunotherapy drugs market. Although these regions currently hold a smaller market share, increasing healthcare investments and improving access to advanced medical treatments are expected to drive growth. Governments in these regions are focusing on enhancing healthcare facilities and promoting research to support market development.

Key Companies

Incyte, Bei Gene, Macro Genics, Adaptimmune Therapeutics, Immunomedics, Kite Pharma, Juno Therapeutics, Immunocore, Bluebird Bio, Celldex Therapeutics, Onco Med Pharmaceuticals, Argenx, Cellectis, Fate Therapeutics, Gritstone Oncology, Adaptimmune, Allogene Therapeutics, Iovance Biotherapeutics, Zymeworks, Compugen

Sources

World Health Organization (WHO), U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institutes of Health (NIH), American Association for Cancer Research (AACR), International Agency for Research on Cancer (IARC), Centers for Disease Control and Prevention (CDC), World Cancer Research Fund International, International Society for Biological Therapy of Cancer (iSBTc), Cancer Research UK, National Cancer Institute (NCI), European Society for Medical Oncology (ESMO), Society for Immunotherapy of Cancer (SITC), National Comprehensive Cancer Network (NCCN), American Society of Clinical Oncology (ASCO), Australian Therapeutic Goods Administration (TGA), Canadian Agency for Drugs and Technologies in Health (CADTH), International Conference on Cancer Immunotherapy, International Immunocompromised Host Society (ICHS), International Cancer Immunotherapy Conference (CICON).

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Immunotherapy Drugs Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Immunotherapy Drugs Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Application
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by End User
  • 2.8 Key Highlights of the Market, by Process
  • 2.9 Key Highlights of the Market, by Mode
  • 2.10 Key Highlights of the Market, by Stage
  • 2.11 Key Highlights of the Market, by North America
  • 2.12 Key Highlights of the Market, by Europe
  • 2.13 Key Highlights of the Market, by Asia-Pacific
  • 2.14 Key Highlights of the Market, by Latin America
  • 2.15 Key Highlights of the Market, by Middle East
  • 2.16 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Application
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by End User
  • 3.7 Market Attractiveness Analysis, by Process
  • 3.8 Market Attractiveness Analysis, by Mode
  • 3.9 Market Attractiveness Analysis, by Stage
  • 3.10 Market Attractiveness Analysis, by North America
  • 3.11 Market Attractiveness Analysis, by Europe
  • 3.12 Market Attractiveness Analysis, by Asia-Pacific
  • 3.13 Market Attractiveness Analysis, by Latin America
  • 3.14 Market Attractiveness Analysis, by Middle East
  • 3.15 Market Attractiveness Analysis, by Africa

4: Immunotherapy Drugs Market Outlook

  • 4.1 Immunotherapy Drugs Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Immunotherapy Drugs Immunotherapy Drugs Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Immunotherapy Drugs Market Size

  • 6.1 Immunotherapy Drugs Market Size, by Value
  • 6.2 Immunotherapy Drugs Market Size, by Volume

7: Immunotherapy Drugs Market, by Type

  • 7.1 Market Overview
  • 7.2 Monoclonal Antibodies
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Checkpoint Inhibitors
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Cytokines
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Cancer Vaccines
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Adoptive Cell Therapy
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Oncolytic Virus Therapy
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 Others
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region

8: Immunotherapy Drugs Market, by Product

  • 8.1 Market Overview
  • 8.2 Therapeutic Vaccines
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Immune Checkpoint Inhibitors
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Non-specific Immunotherapies
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Oncolytic Virus Immunotherapy
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 CAR-T Cell Therapy
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Others
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region

9: Immunotherapy Drugs Market, by Application

  • 9.1 Market Overview
  • 9.2 Cancer
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Autoimmune Diseases
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Infectious Diseases
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Inflammatory Diseases
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: Immunotherapy Drugs Market, by Technology

  • 10.1 Market Overview
  • 10.2 Gene Editing
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 CRISPR
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 RNA Interference
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Nanotechnology
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Recombinant DNA Technology
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Others
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region

11: Immunotherapy Drugs Market, by End User

  • 11.1 Market Overview
  • 11.2 Hospitals
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Clinics
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Research Institutes
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Biopharmaceutical Companies
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Others
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region

12: Immunotherapy Drugs Market, by Process

  • 12.1 Market Overview
  • 12.2 Manufacturing
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Research and Development
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Clinical Trials
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Regulatory Approval
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Commercialization
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region
  • 12.7 Others
    • 12.7.1 Key Market Trends & Opportunity Analysis
    • 12.7.2 Market Size and Forecast, by Region

13: Immunotherapy Drugs Market, by Mode

  • 13.1 Market Overview
  • 13.2 Intravenous
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Oral
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Topical
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Inhalation
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Others
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region

14: Immunotherapy Drugs Market, by Stage

  • 14.1 Market Overview
  • 14.2 Discovery
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Preclinical
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Clinical
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Approval
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Launch
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region
  • 14.7 Post-market Surveillance
    • 14.7.1 Key Market Trends & Opportunity Analysis
    • 14.7.2 Market Size and Forecast, by Region
  • 14.8 Others
    • 14.8.1 Key Market Trends & Opportunity Analysis
    • 14.8.2 Market Size and Forecast, by Region

15: Immunotherapy Drugs Market, by Region

  • 15.1 Overview
  • 15.2 North America
    • 15.2.1 Key Market Trends and Opportunities
    • 15.2.2 North America Market Size and Forecast, by Type
    • 15.2.3 North America Market Size and Forecast, by Product
    • 15.2.4 North America Market Size and Forecast, by Application
    • 15.2.5 North America Market Size and Forecast, by Technology
    • 15.2.6 North America Market Size and Forecast, by End User
    • 15.2.7 North America Market Size and Forecast, by Process
    • 15.2.8 North America Market Size and Forecast, by Mode
    • 15.2.9 North America Market Size and Forecast, by Stage
    • 15.2.10 North America Market Size and Forecast, by Country
    • 15.2.11 United States
      • 15.2.9.1 United States Market Size and Forecast, by Type
      • 15.2.9.2 United States Market Size and Forecast, by Product
      • 15.2.9.3 United States Market Size and Forecast, by Application
      • 15.2.9.4 United States Market Size and Forecast, by Technology
      • 15.2.9.5 United States Market Size and Forecast, by End User
      • 15.2.9.6 United States Market Size and Forecast, by Process
      • 15.2.9.7 United States Market Size and Forecast, by Mode
      • 15.2.9.8 United States Market Size and Forecast, by Stage
      • 15.2.9.9 Local Competition Analysis
      • 15.2.9.10 Local Market Analysis
    • 15.2.1 Canada
      • 15.2.10.1 Canada Market Size and Forecast, by Type
      • 15.2.10.2 Canada Market Size and Forecast, by Product
      • 15.2.10.3 Canada Market Size and Forecast, by Application
      • 15.2.10.4 Canada Market Size and Forecast, by Technology
      • 15.2.10.5 Canada Market Size and Forecast, by End User
      • 15.2.10.6 Canada Market Size and Forecast, by Process
      • 15.2.10.7 Canada Market Size and Forecast, by Mode
      • 15.2.10.8 Canada Market Size and Forecast, by Stage
      • 15.2.10.9 Local Competition Analysis
      • 15.2.10.10 Local Market Analysis
  • 15.1 Europe
    • 15.3.1 Key Market Trends and Opportunities
    • 15.3.2 Europe Market Size and Forecast, by Type
    • 15.3.3 Europe Market Size and Forecast, by Product
    • 15.3.4 Europe Market Size and Forecast, by Application
    • 15.3.5 Europe Market Size and Forecast, by Technology
    • 15.3.6 Europe Market Size and Forecast, by End User
    • 15.3.7 Europe Market Size and Forecast, by Process
    • 15.3.8 Europe Market Size and Forecast, by Mode
    • 15.3.9 Europe Market Size and Forecast, by Stage
    • 15.3.10 Europe Market Size and Forecast, by Country
    • 15.3.11 United Kingdom
      • 15.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 15.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 15.3.9.3 United Kingdom Market Size and Forecast, by Application
      • 15.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 15.3.9.5 United Kingdom Market Size and Forecast, by End User
      • 15.3.9.6 United Kingdom Market Size and Forecast, by Process
      • 15.3.9.7 United Kingdom Market Size and Forecast, by Mode
      • 15.3.9.8 United Kingdom Market Size and Forecast, by Stage
      • 15.3.9.9 Local Competition Analysis
      • 15.3.9.10 Local Market Analysis
    • 15.3.1 Germany
      • 15.3.10.1 Germany Market Size and Forecast, by Type
      • 15.3.10.2 Germany Market Size and Forecast, by Product
      • 15.3.10.3 Germany Market Size and Forecast, by Application
      • 15.3.10.4 Germany Market Size and Forecast, by Technology
      • 15.3.10.5 Germany Market Size and Forecast, by End User
      • 15.3.10.6 Germany Market Size and Forecast, by Process
      • 15.3.10.7 Germany Market Size and Forecast, by Mode
      • 15.3.10.8 Germany Market Size and Forecast, by Stage
      • 15.3.10.9 Local Competition Analysis
      • 15.3.10.10 Local Market Analysis
    • 15.3.1 France
      • 15.3.11.1 France Market Size and Forecast, by Type
      • 15.3.11.2 France Market Size and Forecast, by Product
      • 15.3.11.3 France Market Size and Forecast, by Application
      • 15.3.11.4 France Market Size and Forecast, by Technology
      • 15.3.11.5 France Market Size and Forecast, by End User
      • 15.3.11.6 France Market Size and Forecast, by Process
      • 15.3.11.7 France Market Size and Forecast, by Mode
      • 15.3.11.8 France Market Size and Forecast, by Stage
      • 15.3.11.9 Local Competition Analysis
      • 15.3.11.10 Local Market Analysis
    • 15.3.1 Spain
      • 15.3.12.1 Spain Market Size and Forecast, by Type
      • 15.3.12.2 Spain Market Size and Forecast, by Product
      • 15.3.12.3 Spain Market Size and Forecast, by Application
      • 15.3.12.4 Spain Market Size and Forecast, by Technology
      • 15.3.12.5 Spain Market Size and Forecast, by End User
      • 15.3.12.6 Spain Market Size and Forecast, by Process
      • 15.3.12.7 Spain Market Size and Forecast, by Mode
      • 15.3.12.8 Spain Market Size and Forecast, by Stage
      • 15.3.12.9 Local Competition Analysis
      • 15.3.12.10 Local Market Analysis
    • 15.3.1 Italy
      • 15.3.13.1 Italy Market Size and Forecast, by Type
      • 15.3.13.2 Italy Market Size and Forecast, by Product
      • 15.3.13.3 Italy Market Size and Forecast, by Application
      • 15.3.13.4 Italy Market Size and Forecast, by Technology
      • 15.3.13.5 Italy Market Size and Forecast, by End User
      • 15.3.13.6 Italy Market Size and Forecast, by Process
      • 15.3.13.7 Italy Market Size and Forecast, by Mode
      • 15.3.13.8 Italy Market Size and Forecast, by Stage
      • 15.3.13.9 Local Competition Analysis
      • 15.3.13.10 Local Market Analysis
    • 15.3.1 Netherlands
      • 15.3.14.1 Netherlands Market Size and Forecast, by Type
      • 15.3.14.2 Netherlands Market Size and Forecast, by Product
      • 15.3.14.3 Netherlands Market Size and Forecast, by Application
      • 15.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 15.3.14.5 Netherlands Market Size and Forecast, by End User
      • 15.3.14.6 Netherlands Market Size and Forecast, by Process
      • 15.3.14.7 Netherlands Market Size and Forecast, by Mode
      • 15.3.14.8 Netherlands Market Size and Forecast, by Stage
      • 15.3.14.9 Local Competition Analysis
      • 15.3.14.10 Local Market Analysis
    • 15.3.1 Sweden
      • 15.3.15.1 Sweden Market Size and Forecast, by Type
      • 15.3.15.2 Sweden Market Size and Forecast, by Product
      • 15.3.15.3 Sweden Market Size and Forecast, by Application
      • 15.3.15.4 Sweden Market Size and Forecast, by Technology
      • 15.3.15.5 Sweden Market Size and Forecast, by End User
      • 15.3.15.6 Sweden Market Size and Forecast, by Process
      • 15.3.15.7 Sweden Market Size and Forecast, by Mode
      • 15.3.15.8 Sweden Market Size and Forecast, by Stage
      • 15.3.15.9 Local Competition Analysis
      • 15.3.15.10 Local Market Analysis
    • 15.3.1 Switzerland
      • 15.3.16.1 Switzerland Market Size and Forecast, by Type
      • 15.3.16.2 Switzerland Market Size and Forecast, by Product
      • 15.3.16.3 Switzerland Market Size and Forecast, by Application
      • 15.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 15.3.16.5 Switzerland Market Size and Forecast, by End User
      • 15.3.16.6 Switzerland Market Size and Forecast, by Process
      • 15.3.16.7 Switzerland Market Size and Forecast, by Mode
      • 15.3.16.8 Switzerland Market Size and Forecast, by Stage
      • 15.3.16.9 Local Competition Analysis
      • 15.3.16.10 Local Market Analysis
    • 15.3.1 Denmark
      • 15.3.17.1 Denmark Market Size and Forecast, by Type
      • 15.3.17.2 Denmark Market Size and Forecast, by Product
      • 15.3.17.3 Denmark Market Size and Forecast, by Application
      • 15.3.17.4 Denmark Market Size and Forecast, by Technology
      • 15.3.17.5 Denmark Market Size and Forecast, by End User
      • 15.3.17.6 Denmark Market Size and Forecast, by Process
      • 15.3.17.7 Denmark Market Size and Forecast, by Mode
      • 15.3.17.8 Denmark Market Size and Forecast, by Stage
      • 15.3.17.9 Local Competition Analysis
      • 15.3.17.10 Local Market Analysis
    • 15.3.1 Finland
      • 15.3.18.1 Finland Market Size and Forecast, by Type
      • 15.3.18.2 Finland Market Size and Forecast, by Product
      • 15.3.18.3 Finland Market Size and Forecast, by Application
      • 15.3.18.4 Finland Market Size and Forecast, by Technology
      • 15.3.18.5 Finland Market Size and Forecast, by End User
      • 15.3.18.6 Finland Market Size and Forecast, by Process
      • 15.3.18.7 Finland Market Size and Forecast, by Mode
      • 15.3.18.8 Finland Market Size and Forecast, by Stage
      • 15.3.18.9 Local Competition Analysis
      • 15.3.18.10 Local Market Analysis
    • 15.3.1 Russia
      • 15.3.19.1 Russia Market Size and Forecast, by Type
      • 15.3.19.2 Russia Market Size and Forecast, by Product
      • 15.3.19.3 Russia Market Size and Forecast, by Application
      • 15.3.19.4 Russia Market Size and Forecast, by Technology
      • 15.3.19.5 Russia Market Size and Forecast, by End User
      • 15.3.19.6 Russia Market Size and Forecast, by Process
      • 15.3.19.7 Russia Market Size and Forecast, by Mode
      • 15.3.19.8 Russia Market Size and Forecast, by Stage
      • 15.3.19.9 Local Competition Analysis
      • 15.3.19.10 Local Market Analysis
    • 15.3.1 Rest of Europe
      • 15.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 15.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 15.3.20.3 Rest of Europe Market Size and Forecast, by Application
      • 15.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 15.3.20.5 Rest of Europe Market Size and Forecast, by End User
      • 15.3.20.6 Rest of Europe Market Size and Forecast, by Process
      • 15.3.20.7 Rest of Europe Market Size and Forecast, by Mode
      • 15.3.20.8 Rest of Europe Market Size and Forecast, by Stage
      • 15.3.20.9 Local Competition Analysis
      • 15.3.20.10 Local Market Analysis
  • 15.1 Asia-Pacific
    • 15.4.1 Key Market Trends and Opportunities
    • 15.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 15.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 15.4.4 Asia-Pacific Market Size and Forecast, by Application
    • 15.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 15.4.6 Asia-Pacific Market Size and Forecast, by End User
    • 15.4.7 Asia-Pacific Market Size and Forecast, by Process
    • 15.4.8 Asia-Pacific Market Size and Forecast, by Mode
    • 15.4.9 Asia-Pacific Market Size and Forecast, by Stage
    • 15.4.10 Asia-Pacific Market Size and Forecast, by Country
    • 15.4.11 China
      • 15.4.9.1 China Market Size and Forecast, by Type
      • 15.4.9.2 China Market Size and Forecast, by Product
      • 15.4.9.3 China Market Size and Forecast, by Application
      • 15.4.9.4 China Market Size and Forecast, by Technology
      • 15.4.9.5 China Market Size and Forecast, by End User
      • 15.4.9.6 China Market Size and Forecast, by Process
      • 15.4.9.7 China Market Size and Forecast, by Mode
      • 15.4.9.8 China Market Size and Forecast, by Stage
      • 15.4.9.9 Local Competition Analysis
      • 15.4.9.10 Local Market Analysis
    • 15.4.1 India
      • 15.4.10.1 India Market Size and Forecast, by Type
      • 15.4.10.2 India Market Size and Forecast, by Product
      • 15.4.10.3 India Market Size and Forecast, by Application
      • 15.4.10.4 India Market Size and Forecast, by Technology
      • 15.4.10.5 India Market Size and Forecast, by End User
      • 15.4.10.6 India Market Size and Forecast, by Process
      • 15.4.10.7 India Market Size and Forecast, by Mode
      • 15.4.10.8 India Market Size and Forecast, by Stage
      • 15.4.10.9 Local Competition Analysis
      • 15.4.10.10 Local Market Analysis
    • 15.4.1 Japan
      • 15.4.11.1 Japan Market Size and Forecast, by Type
      • 15.4.11.2 Japan Market Size and Forecast, by Product
      • 15.4.11.3 Japan Market Size and Forecast, by Application
      • 15.4.11.4 Japan Market Size and Forecast, by Technology
      • 15.4.11.5 Japan Market Size and Forecast, by End User
      • 15.4.11.6 Japan Market Size and Forecast, by Process
      • 15.4.11.7 Japan Market Size and Forecast, by Mode
      • 15.4.11.8 Japan Market Size and Forecast, by Stage
      • 15.4.11.9 Local Competition Analysis
      • 15.4.11.10 Local Market Analysis
    • 15.4.1 South Korea
      • 15.4.12.1 South Korea Market Size and Forecast, by Type
      • 15.4.12.2 South Korea Market Size and Forecast, by Product
      • 15.4.12.3 South Korea Market Size and Forecast, by Application
      • 15.4.12.4 South Korea Market Size and Forecast, by Technology
      • 15.4.12.5 South Korea Market Size and Forecast, by End User
      • 15.4.12.6 South Korea Market Size and Forecast, by Process
      • 15.4.12.7 South Korea Market Size and Forecast, by Mode
      • 15.4.12.8 South Korea Market Size and Forecast, by Stage
      • 15.4.12.9 Local Competition Analysis
      • 15.4.12.10 Local Market Analysis
    • 15.4.1 Australia
      • 15.4.13.1 Australia Market Size and Forecast, by Type
      • 15.4.13.2 Australia Market Size and Forecast, by Product
      • 15.4.13.3 Australia Market Size and Forecast, by Application
      • 15.4.13.4 Australia Market Size and Forecast, by Technology
      • 15.4.13.5 Australia Market Size and Forecast, by End User
      • 15.4.13.6 Australia Market Size and Forecast, by Process
      • 15.4.13.7 Australia Market Size and Forecast, by Mode
      • 15.4.13.8 Australia Market Size and Forecast, by Stage
      • 15.4.13.9 Local Competition Analysis
      • 15.4.13.10 Local Market Analysis
    • 15.4.1 Singapore
      • 15.4.14.1 Singapore Market Size and Forecast, by Type
      • 15.4.14.2 Singapore Market Size and Forecast, by Product
      • 15.4.14.3 Singapore Market Size and Forecast, by Application
      • 15.4.14.4 Singapore Market Size and Forecast, by Technology
      • 15.4.14.5 Singapore Market Size and Forecast, by End User
      • 15.4.14.6 Singapore Market Size and Forecast, by Process
      • 15.4.14.7 Singapore Market Size and Forecast, by Mode
      • 15.4.14.8 Singapore Market Size and Forecast, by Stage
      • 15.4.14.9 Local Competition Analysis
      • 15.4.14.10 Local Market Analysis
    • 15.4.1 Indonesia
      • 15.4.15.1 Indonesia Market Size and Forecast, by Type
      • 15.4.15.2 Indonesia Market Size and Forecast, by Product
      • 15.4.15.3 Indonesia Market Size and Forecast, by Application
      • 15.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 15.4.15.5 Indonesia Market Size and Forecast, by End User
      • 15.4.15.6 Indonesia Market Size and Forecast, by Process
      • 15.4.15.7 Indonesia Market Size and Forecast, by Mode
      • 15.4.15.8 Indonesia Market Size and Forecast, by Stage
      • 15.4.15.9 Local Competition Analysis
      • 15.4.15.10 Local Market Analysis
    • 15.4.1 Taiwan
      • 15.4.16.1 Taiwan Market Size and Forecast, by Type
      • 15.4.16.2 Taiwan Market Size and Forecast, by Product
      • 15.4.16.3 Taiwan Market Size and Forecast, by Application
      • 15.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 15.4.16.5 Taiwan Market Size and Forecast, by End User
      • 15.4.16.6 Taiwan Market Size and Forecast, by Process
      • 15.4.16.7 Taiwan Market Size and Forecast, by Mode
      • 15.4.16.8 Taiwan Market Size and Forecast, by Stage
      • 15.4.16.9 Local Competition Analysis
      • 15.4.16.10 Local Market Analysis
    • 15.4.1 Malaysia
      • 15.4.17.1 Malaysia Market Size and Forecast, by Type
      • 15.4.17.2 Malaysia Market Size and Forecast, by Product
      • 15.4.17.3 Malaysia Market Size and Forecast, by Application
      • 15.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 15.4.17.5 Malaysia Market Size and Forecast, by End User
      • 15.4.17.6 Malaysia Market Size and Forecast, by Process
      • 15.4.17.7 Malaysia Market Size and Forecast, by Mode
      • 15.4.17.8 Malaysia Market Size and Forecast, by Stage
      • 15.4.17.9 Local Competition Analysis
      • 15.4.17.10 Local Market Analysis
    • 15.4.1 Rest of Asia-Pacific
      • 15.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 15.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 15.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 15.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 15.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 15.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 15.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 15.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 15.4.18.9 Local Competition Analysis
      • 15.4.18.10 Local Market Analysis
  • 15.1 Latin America
    • 15.5.1 Key Market Trends and Opportunities
    • 15.5.2 Latin America Market Size and Forecast, by Type
    • 15.5.3 Latin America Market Size and Forecast, by Product
    • 15.5.4 Latin America Market Size and Forecast, by Application
    • 15.5.5 Latin America Market Size and Forecast, by Technology
    • 15.5.6 Latin America Market Size and Forecast, by End User
    • 15.5.7 Latin America Market Size and Forecast, by Process
    • 15.5.8 Latin America Market Size and Forecast, by Mode
    • 15.5.9 Latin America Market Size and Forecast, by Stage
    • 15.5.10 Latin America Market Size and Forecast, by Country
    • 15.5.11 Brazil
      • 15.5.9.1 Brazil Market Size and Forecast, by Type
      • 15.5.9.2 Brazil Market Size and Forecast, by Product
      • 15.5.9.3 Brazil Market Size and Forecast, by Application
      • 15.5.9.4 Brazil Market Size and Forecast, by Technology
      • 15.5.9.5 Brazil Market Size and Forecast, by End User
      • 15.5.9.6 Brazil Market Size and Forecast, by Process
      • 15.5.9.7 Brazil Market Size and Forecast, by Mode
      • 15.5.9.8 Brazil Market Size and Forecast, by Stage
      • 15.5.9.9 Local Competition Analysis
      • 15.5.9.10 Local Market Analysis
    • 15.5.1 Mexico
      • 15.5.10.1 Mexico Market Size and Forecast, by Type
      • 15.5.10.2 Mexico Market Size and Forecast, by Product
      • 15.5.10.3 Mexico Market Size and Forecast, by Application
      • 15.5.10.4 Mexico Market Size and Forecast, by Technology
      • 15.5.10.5 Mexico Market Size and Forecast, by End User
      • 15.5.10.6 Mexico Market Size and Forecast, by Process
      • 15.5.10.7 Mexico Market Size and Forecast, by Mode
      • 15.5.10.8 Mexico Market Size and Forecast, by Stage
      • 15.5.10.9 Local Competition Analysis
      • 15.5.10.10 Local Market Analysis
    • 15.5.1 Argentina
      • 15.5.11.1 Argentina Market Size and Forecast, by Type
      • 15.5.11.2 Argentina Market Size and Forecast, by Product
      • 15.5.11.3 Argentina Market Size and Forecast, by Application
      • 15.5.11.4 Argentina Market Size and Forecast, by Technology
      • 15.5.11.5 Argentina Market Size and Forecast, by End User
      • 15.5.11.6 Argentina Market Size and Forecast, by Process
      • 15.5.11.7 Argentina Market Size and Forecast, by Mode
      • 15.5.11.8 Argentina Market Size and Forecast, by Stage
      • 15.5.11.9 Local Competition Analysis
      • 15.5.11.10 Local Market Analysis
    • 15.5.1 Rest of Latin America
      • 15.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 15.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 15.5.12.3 Rest of Latin America Market Size and Forecast, by Application
      • 15.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 15.5.12.5 Rest of Latin America Market Size and Forecast, by End User
      • 15.5.12.6 Rest of Latin America Market Size and Forecast, by Process
      • 15.5.12.7 Rest of Latin America Market Size and Forecast, by Mode
      • 15.5.12.8 Rest of Latin America Market Size and Forecast, by Stage
      • 15.5.12.9 Local Competition Analysis
      • 15.5.12.10 Local Market Analysis
  • 15.1 Middle East and Africa
    • 15.6.1 Key Market Trends and Opportunities
    • 15.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 15.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 15.6.4 Middle East and Africa Market Size and Forecast, by Application
    • 15.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 15.6.6 Middle East and Africa Market Size and Forecast, by End User
    • 15.6.7 Middle East and Africa Market Size and Forecast, by Process
    • 15.6.8 Middle East and Africa Market Size and Forecast, by Mode
    • 15.6.9 Middle East and Africa Market Size and Forecast, by Stage
    • 15.6.10 Middle East and Africa Market Size and Forecast, by Country
    • 15.6.11 Saudi Arabia
      • 15.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 15.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 15.6.9.3 Saudi Arabia Market Size and Forecast, by Application
      • 15.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 15.6.9.5 Saudi Arabia Market Size and Forecast, by End User
      • 15.6.9.6 Saudi Arabia Market Size and Forecast, by Process
      • 15.6.9.7 Saudi Arabia Market Size and Forecast, by Mode
      • 15.6.9.8 Saudi Arabia Market Size and Forecast, by Stage
      • 15.6.9.9 Local Competition Analysis
      • 15.6.9.10 Local Market Analysis
    • 15.6.1 UAE
      • 15.6.10.1 UAE Market Size and Forecast, by Type
      • 15.6.10.2 UAE Market Size and Forecast, by Product
      • 15.6.10.3 UAE Market Size and Forecast, by Application
      • 15.6.10.4 UAE Market Size and Forecast, by Technology
      • 15.6.10.5 UAE Market Size and Forecast, by End User
      • 15.6.10.6 UAE Market Size and Forecast, by Process
      • 15.6.10.7 UAE Market Size and Forecast, by Mode
      • 15.6.10.8 UAE Market Size and Forecast, by Stage
      • 15.6.10.9 Local Competition Analysis
      • 15.6.10.10 Local Market Analysis
    • 15.6.1 South Africa
      • 15.6.11.1 South Africa Market Size and Forecast, by Type
      • 15.6.11.2 South Africa Market Size and Forecast, by Product
      • 15.6.11.3 South Africa Market Size and Forecast, by Application
      • 15.6.11.4 South Africa Market Size and Forecast, by Technology
      • 15.6.11.5 South Africa Market Size and Forecast, by End User
      • 15.6.11.6 South Africa Market Size and Forecast, by Process
      • 15.6.11.7 South Africa Market Size and Forecast, by Mode
      • 15.6.11.8 South Africa Market Size and Forecast, by Stage
      • 15.6.11.9 Local Competition Analysis
      • 15.6.11.10 Local Market Analysis
    • 15.6.1 Rest of MEA
      • 15.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 15.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 15.6.12.3 Rest of MEA Market Size and Forecast, by Application
      • 15.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 15.6.12.5 Rest of MEA Market Size and Forecast, by End User
      • 15.6.12.6 Rest of MEA Market Size and Forecast, by Process
      • 15.6.12.7 Rest of MEA Market Size and Forecast, by Mode
      • 15.6.12.8 Rest of MEA Market Size and Forecast, by Stage
      • 15.6.12.9 Local Competition Analysis
      • 15.6.12.10 Local Market Analysis

16: Competitive Landscape

  • 16.1 Overview
  • 16.2 Market Share Analysis
  • 16.3 Key Player Positioning
  • 16.4 Competitive Leadership Mapping
    • 16.4.1 Star Players
    • 16.4.2 Innovators
    • 16.4.3 Emerging Players
  • 16.5 Vendor Benchmarking
  • 16.6 Developmental Strategy Benchmarking
    • 16.6.1 New Product Developments
    • 16.6.2 Product Launches
    • 16.6.3 Business Expansions
    • 16.6.4 Partnerships, Joint Ventures, and Collaborations
    • 16.6.5 Mergers and Acquisitions

17: Company Profiles

  • 17.1 Incyte
    • 17.1.1 Company Overview
    • 17.1.2 Company Snapshot
    • 17.1.3 Business Segments
    • 17.1.4 Business Performance
    • 17.1.5 Product Offerings
    • 17.1.6 Key Developmental Strategies
    • 17.1.7 SWOT Analysis
  • 17.2 BeiGene
    • 17.2.1 Company Overview
    • 17.2.2 Company Snapshot
    • 17.2.3 Business Segments
    • 17.2.4 Business Performance
    • 17.2.5 Product Offerings
    • 17.2.6 Key Developmental Strategies
    • 17.2.7 SWOT Analysis
  • 17.3 MacroGenics
    • 17.3.1 Company Overview
    • 17.3.2 Company Snapshot
    • 17.3.3 Business Segments
    • 17.3.4 Business Performance
    • 17.3.5 Product Offerings
    • 17.3.6 Key Developmental Strategies
    • 17.3.7 SWOT Analysis
  • 17.4 Adaptimmune Therapeutics
    • 17.4.1 Company Overview
    • 17.4.2 Company Snapshot
    • 17.4.3 Business Segments
    • 17.4.4 Business Performance
    • 17.4.5 Product Offerings
    • 17.4.6 Key Developmental Strategies
    • 17.4.7 SWOT Analysis
  • 17.5 Immunomedics
    • 17.5.1 Company Overview
    • 17.5.2 Company Snapshot
    • 17.5.3 Business Segments
    • 17.5.4 Business Performance
    • 17.5.5 Product Offerings
    • 17.5.6 Key Developmental Strategies
    • 17.5.7 SWOT Analysis
  • 17.6 Kite Pharma
    • 17.6.1 Company Overview
    • 17.6.2 Company Snapshot
    • 17.6.3 Business Segments
    • 17.6.4 Business Performance
    • 17.6.5 Product Offerings
    • 17.6.6 Key Developmental Strategies
    • 17.6.7 SWOT Analysis
  • 17.7 Juno Therapeutics
    • 17.7.1 Company Overview
    • 17.7.2 Company Snapshot
    • 17.7.3 Business Segments
    • 17.7.4 Business Performance
    • 17.7.5 Product Offerings
    • 17.7.6 Key Developmental Strategies
    • 17.7.7 SWOT Analysis
  • 17.8 Immunocore
    • 17.8.1 Company Overview
    • 17.8.2 Company Snapshot
    • 17.8.3 Business Segments
    • 17.8.4 Business Performance
    • 17.8.5 Product Offerings
    • 17.8.6 Key Developmental Strategies
    • 17.8.7 SWOT Analysis
  • 17.9 Bluebird Bio
    • 17.9.1 Company Overview
    • 17.9.2 Company Snapshot
    • 17.9.3 Business Segments
    • 17.9.4 Business Performance
    • 17.9.5 Product Offerings
    • 17.9.6 Key Developmental Strategies
    • 17.9.7 SWOT Analysis
  • 17.10 Celldex Therapeutics
    • 17.10.1 Company Overview
    • 17.10.2 Company Snapshot
    • 17.10.3 Business Segments
    • 17.10.4 Business Performance
    • 17.10.5 Product Offerings
    • 17.10.6 Key Developmental Strategies
    • 17.10.7 SWOT Analysis
  • 17.11 OncoMed Pharmaceuticals
    • 17.11.1 Company Overview
    • 17.11.2 Company Snapshot
    • 17.11.3 Business Segments
    • 17.11.4 Business Performance
    • 17.11.5 Product Offerings
    • 17.11.6 Key Developmental Strategies
    • 17.11.7 SWOT Analysis
  • 17.12 Argenx
    • 17.12.1 Company Overview
    • 17.12.2 Company Snapshot
    • 17.12.3 Business Segments
    • 17.12.4 Business Performance
    • 17.12.5 Product Offerings
    • 17.12.6 Key Developmental Strategies
    • 17.12.7 SWOT Analysis
  • 17.13 Cellectis
    • 17.13.1 Company Overview
    • 17.13.2 Company Snapshot
    • 17.13.3 Business Segments
    • 17.13.4 Business Performance
    • 17.13.5 Product Offerings
    • 17.13.6 Key Developmental Strategies
    • 17.13.7 SWOT Analysis
  • 17.14 Fate Therapeutics
    • 17.14.1 Company Overview
    • 17.14.2 Company Snapshot
    • 17.14.3 Business Segments
    • 17.14.4 Business Performance
    • 17.14.5 Product Offerings
    • 17.14.6 Key Developmental Strategies
    • 17.14.7 SWOT Analysis
  • 17.15 Gritstone Oncology
    • 17.15.1 Company Overview
    • 17.15.2 Company Snapshot
    • 17.15.3 Business Segments
    • 17.15.4 Business Performance
    • 17.15.5 Product Offerings
    • 17.15.6 Key Developmental Strategies
    • 17.15.7 SWOT Analysis
  • 17.16 Adaptimmune
    • 17.16.1 Company Overview
    • 17.16.2 Company Snapshot
    • 17.16.3 Business Segments
    • 17.16.4 Business Performance
    • 17.16.5 Product Offerings
    • 17.16.6 Key Developmental Strategies
    • 17.16.7 SWOT Analysis
  • 17.17 Allogene Therapeutics
    • 17.17.1 Company Overview
    • 17.17.2 Company Snapshot
    • 17.17.3 Business Segments
    • 17.17.4 Business Performance
    • 17.17.5 Product Offerings
    • 17.17.6 Key Developmental Strategies
    • 17.17.7 SWOT Analysis
  • 17.18 Iovance Biotherapeutics
    • 17.18.1 Company Overview
    • 17.18.2 Company Snapshot
    • 17.18.3 Business Segments
    • 17.18.4 Business Performance
    • 17.18.5 Product Offerings
    • 17.18.6 Key Developmental Strategies
    • 17.18.7 SWOT Analysis
  • 17.19 Zymeworks
    • 17.19.1 Company Overview
    • 17.19.2 Company Snapshot
    • 17.19.3 Business Segments
    • 17.19.4 Business Performance
    • 17.19.5 Product Offerings
    • 17.19.6 Key Developmental Strategies
    • 17.19.7 SWOT Analysis
  • 17.20 Compugen
    • 17.20.1 Company Overview
    • 17.20.2 Company Snapshot
    • 17.20.3 Business Segments
    • 17.20.4 Business Performance
    • 17.20.5 Product Offerings
    • 17.20.6 Key Developmental Strategies
    • 17.20.7 SWOT Analysis